The team’s Clingon platform helps clinical biologists to reach timely conclusions about patients’ genetic diseases
- Age of business: Founded in 2014
- Name of business: HybridStat
- Location: Athens, Greece
- Team: Panagiotis Moulos, Ioannis Kanaris, Efthimios Bothos, Orsalia Hazapis, Marielena Georgaki
- Funding: €86,000
What does HybridStat do?
HybridStat develops Clingon, a cloud-based clinical genomics decision support system integrating open gene and human disease data for clinical diagnosis and personalised medicine. Clingon helps clinical biologists to reach timely conclusions regarding patient genetic diseases.
How did you meet?
Panos and Ioannis were PhD students in the same lab. Then Ioannis met Thimios during his military service. In 2013 we started sending out tenders for bioinformatics projects. We got the first job in 2014 and HybridStat was established. Orsalia and Marielena came aboard to support the development of Clingon.
Where did the business idea come from?
The use of genomics for clinical decision support is becoming a standard procedure in molecular diagnostics labs we are collaborating with. We observed their processes and we identified an opportunity on improving them through a cloud based solution that is user-friendly and supports them in reducing their turnaround times.
Are you working with any other partners?
We are collaborating with major biological and biomedical research institutes in Greece. For the Clingon product we are closely working with Genomedica SA, a leading molecular diagnostics lab in Greece. During 2015 we were part of EkinisiLab, a business development incubator in Athens.
How has ODINE helped you so far?
ODINE has provided us the resources to start the development of our Clingon product. With the provided funding we have expanded our team and we are implementing our product, while with advice from the mentors we have improved our marketing strategy and business model.
What advice would you give to other companies pitching to ODINE?
Make sure that you clearly explain the added value you are offering to your target users. Know what you are implementing, how you are using open data and who your customers are, as you have six months to implement your idea and make your first sales!
How would you encourage big business to buy into the open data movement?
Big businesses that profit from the use of open data need to contribute to the ecosystem by financially supporting open data initiatives or providing new open data to the community.
What’s the key trend in open data at the moment?
Open data nourish novel ideas for improving our everyday life. In our field, the constant growth in biological open data may lead to novel treatments of diseases such as cancer.
(This article first appeared on the Guardian)